The global sales of suture needles are estimated to be worth USD 625.0 million in 2024 and anticipated to reach a value of USD 1,008.3 million by 2034. Sales are projected to rise at a CAGR of 4.9% over the forecast period between 2024 and 2034. The revenue generated by suture needles in 2023 was USD 595.8 million.
With increasing awareness about the safety of patients and infection control in healthcare institutions, the demand for suture needles will also increase. As more and more healthcare institutions are working toward the prevention of complications and ensuring efficient healing with minimal or no side effects, so will the demand for suture needles.
This change will have massive ramifications on the rise, acceptance, and market dynamics of suture needles and will continue to drive innovations and purchasing decisions within the healthcare domain.
Probably, surgical procedures are two of the most important factors in modern healthcare. Such factors have a variety of significance: infection control and safety for patients are related to wound complications.
Global Suture Needles Industry Assessment
| Attributes | Key Insights |
|---|---|
| Historical Size, 2023 | USD 595.8 million |
| Estimated Size, 2024 | USD 625.0 million |
| Projected Size, 2034 | USD 1,008.3 million |
| Value-based CAGR (2024 to 2034) | 4.9% |
Wound infections and complications may bring about a series of adverse outcomes for the patient, such as extended hospitalization and increased treatment costs. Because of these factors, there is an enhanced interest among health service providers in practices and technologies that provide the least potential of infection and ensure the best closure of wounds.
Advances in veterinary medicine and technology have vastly changed the files. Contaminated instruments, suture handling, and pathogens in the surgical field all lead to surgical wound infections. Efficient wound closure clearly requires more than accurate suturing techniques in solving these problems; it also mandates the use of materials and devices with infection-preventing properties integral to their structure.
This heightened focus on safety could create demand for advanced suture needles that are equipped with risk-reducing attributes.
Because of this, innovation and marketing of suture needles by manufacturers are increasingly being based on these priorities. Safer and more effective suture needles will continue to find increased adoption as healthcare providers seek solutions that meet the changing standards in patient safety and infection control.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The below table presents the expected CAGR for the global Suture Needles Market over several semi-annual periods spanning from 2024 to 2034. In the first half (H1) of the decade from 2023 to 2033, the business is predicted to surge at a CAGR of 6.0%, followed by a slightly lower growth rate of 5.5% in the second half (H2) of the same decade.
| Particular | Value CAGR |
|---|---|
| H1 | 6.0% (2023 to 2033) |
| H2 | 5.5% (2023 to 2033) |
| H1 | 4.9% (2024 to 2034) |
| H2 | 4.5% (2024 to 2034) |
The above table presents the expected CAGR for the global suture needles market over several semi-annual periods spanning from 2024 to 2034. In the first half (H1) of the decade from 2023 to 2033, the business is predicted to surge at a CAGR of 6.0%, followed by a slightly decline in growth rate of 5.5% in the second half (H2) of the same decade.
Moving into the subsequent period, from H1 2024 to H2 2034, the CAGR is projected to decrease slightly to 4.9% in the first half and increase moderately at 4.5% in the second half. In the first half (H1) the market witnessed a decrease of -110.00 BPS while in the second half (H2), the market witnessed a decrease of -100.00 BPS.
As Surgeries Become More Common Due to Demographic Shifts, Demand for Reliable and Specialized Suture Needles Has Significantly Increased.
The United Nations Population Division estimates that the number of persons aged 65 years and over would double in the next three decades to reach 1.6 billion by 2050.
With increase in age, human health is susceptible to many chronic disorders. Cardiac heart valves, especially the aortic valves, are prone to degenerative changes that eventually culminate in diseases such as aortic stenosis. Aortic stenosis is a condition that arises due to narrowing of the valve opening, with the outcome being reduction in the flow of blood from the heart to the rest of the body.
In severe conditions, surgical repair or even replacement of valves is necessary. Whether it is the correct placement of a prosthetic valve or the mending of an existing one, proper function without leakage and with the assurance of not failing again within a short period has to be ensured, and all this needs to be done with exact suture.
Such scrupulous suturing is very important for the overall long-term success of surgery and recovery; therefore, only the best quality suture needles will be effective.
This would be similarly the case with prostate cancer in older men, where a prostatectomy might be needed to partially or completely remove the organ. It is usually done in those cases where the cancer has not yet spread beyond the prostate or, as in benign prostatic hyperplasia, when it obstructs the normal process of urination to a great degree.
Effective suturing after prostatectomy is quite essential to properly close the incision and correctly align and support the surrounding tissues, like the bladder and the urethra.
The need for new and reliable suture needles in healthcare is therefore increasing in the light of this increase in the adult populating afflicted by these conditions.
The Suture Needles Market Is Undergoing a Transformative Shift, Largely Driven by Advancements in Biomaterials.
The innovations introduced into the use of biomaterials has changed the aspects of surgical procedures and open up new opportunities for suture needles market growth. A deep understanding of how advanced biomaterials are impacting this market provides insight into larger issues of healthcare and industry. For instance, PGA and PLLA are polymers used in making sutures that are slowly digested in the body.
This obviates the process of removal of sutures and at the same time minimizes the risk of infections or foreign body reactions. In internal operations where retention of sutures for long is not necessary, this becomes very useful.
Advanced biomaterials are manufactured materials that would interact with biological systems for medical applications. Such materials are designed to be biocompatible and promote the body's natural healing while minimizing adverse reactions. Relating this to suture needles, biomaterials play a very critical role in enhancing performance and safety, hence the outcomes in patients.
While traditional stainless steel needles are reliable, the score is low in terms of flexibility and sharpness. Biomaterials, like high-strength polymers and metal alloys, has enable the creation of sharper and more resilient needles.
Advanced biomaterials exhibit enhanced biocompatibility than the conventional ones. For instance, bioresorbable materials are naturally absorbed in the body and hence don't require the removal of the suture material. These reduce the incidence of complications that may arise later in life. There is almost no risk of chronic inflammation or non-specific adverse reactions, especially for internal sutures.
Increased Surgical Precision and Pain Management is Fueling the Growth for Suture Needles Market
Advanced technological adoption and innovation have driven the suture needles market to gain higher surgical precision and better pain management. Consistently, surgeons and health service providers want to perfect the precision of any given surgical procedure, alongside trying to minimize discomfort for patients and ensure faster recovery.
All the above factors further shape demand for the suture needles market in terms of development of products and manufacturers' strategy.
The precision of surgery is not only related to the abilities of a surgeon but also, in direct proportion, to how effective his tools and the materials used are. The growing sophistication of surgical techniques increases the demands for precision-engineered suture needles.
In bioresorbable sutures, the needles need to smoothly pass through the material without structurally weakening it. In antimicrobial-coated sutures, needles shall not rupture the coating because the preservation of this very coat is important for the prevention of infections.
This brings out the fact that there has to be constant innovation of needles in terms of technology to ensure compatibility and perfect harmony as the technologies of the materials continue to develop.
For example, ultra-sharp-tipped needles having smooth coatings allow easier passage through the tissues, which reduces the actual physical trauma of suturing and hence the resultant pain in the patients.
The two most significant factors in improving the outcome for the patient are effectively managed pain and accelerated recovery. The precision of wound closure has an influence on the degree of postoperative pain and on time-to-recovery.
If the sutures are well placed, tight, and the needle is cut properly, this will decrease the incidence of certain complications like wound disruption or infection, thus making postoperative pain less and resulting in a quicker recovery process.
The Severity of Needlestick Injuries is the Major Challenge for Suture Needles Market
Needle stick injuries possess as one of the major restraints for the suture needles market due to the nature of the accidents involving punctures from these needles. Needle stick injuries are quite common within healthcare settings and may be of serious concern to health workers and patients.
The impact of needle-stick injuries goes beyond health issues and questions of safety and also influences dynamics in the market, product development, and practices by regulators of the suture needles sector.
Needle-stick injuries is health hazard for the patients as well as healthcare workers. This provide entry for bloodborne pathogens such as HIV, Hepatitis B, and Hepatitis C leading to exposure of lethal diseases. The risk of acquiring such illnesses requires strict safety measures and safer engineering of needles.
Such high risks associated with the occurrence of such infections bring out the need for innovations in suture needle design and handling.
For instance, the FDA and European Medicines Agency set guidelines that helped to spur the design, development, and diffusion of safety-engineered needles.
These regulations encourage the implementation of safer needle technologies to reduce the incidence of a stick from a needle. Compliance with these standards is very labor-intensive and expensive for manufacturers. The need to comply with these regulations could delay product launches, thus adding to R&D expenses.
Furthermore, constant upgrading of product designs and safety features for regulatory compliance drags on market dynamics.
Treating such injuries has therefore increased the focus on developing safer needle technologies, impacting production costs and market dynamics.
Principal Consultant
The global suture needles industry recorded a CAGR of 4.1% during the historical period between 2019 and 2023. The growth of suture needles industry was positive as it reached a value of USD 595.8 million in 2023 from USD 483.2 million in 2019.
Developed healthcare infrastructure, especially in the case of emerging economies, has increased access to surgical procedures and hence raised demand for suture needles. More hospitals, surgical centers, and better-equipped systems of healthcare have placed surgical interventions at the reach of many more people.
The other major factors that continue to feed this demand are technological innovations in the form of advanced absorbable sutures and new designs of the needle.
With enhanced healthcare standards globally, there will be a continuous demand for the highest quality surgical instruments, including suture needles. The increasing demand is suture needles upon the requirement of precision, safety, and efficiency in surgical procedures.
Suture needle manufacturers view this as a challenge and substantially invest in research and development activities to come out with new products meeting the emerging requirements of health institutions. It is key to serving diverse needs in modern surgical practice, such as innovations in needle design and materials.
In addition, the averseness to wound closure via surgical means has fueled the availability of substitutes in form of adhesive strips and staplers, hence reducing the demand for traditional suture needles.
Tier 1 companies comprise market leaders with a market revenue of above USD 100 million capturing significant market share of 56.6% in global market. Tier 1 companies focus on expanding their market presence in emerging economies by establishing local manufacturing facilities, distribution networks, and partnerships.
This strategy helps them tap into growing healthcare markets and address local demands more effectively. These companies implement rigorous quality control processes and ensure their products comply with international standards to build trust and credibility in the market.
Prominent companies in tier 1 include Medtronic, Futura Surgicare Pvt. Ltd., Johnson & Johnson Medical N.V., Aurolab, Alfresa Pharma Corporation and Bear Medic Corporation.
Tier 2 companies include mid-size players with revenue of USd 50 to 100 million having presence in specific regions and highly influencing the local market and holds around 29.6% market share. Tier 2 companies often specialize in specific segments of the market, such as developing suture needles for particular types of surgeries or materials.
This targeted approach allows them to become experts in niche areas and cater to specific needs that larger players might overlook. Prominent companies in tier 2 include SUTUREX & RENODEX, Teleflex Incorporated, Smith & Nephew and Hu-Friedy Mfg. Co. LLC.
Finally, Tier 3 companies, such as FSSB Chirurgische Nadlen GmbH, Burtons Medical Equipment Ltd. and Advin Health Care. These market players specialize in specific products and cater to niche markets, adding diversity to the industry.
Overall, while Tier 1 companies are the primary drivers of the market, Tier 2 and 3 companies also make significant contributions, ensuring the Suture Needles sales remains dynamic and competitive.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The section below covers the industry analysis for the suture needles market for different countries. Market demand analysis on key countries in several regions of the globe, including North America, Asia Pacific, Europe, and others, is provided. The United States is anticipated to remain at the forefront in North America, with higher market share through 2034. In Asia Pacific, India is projected to witness a CAGR of 5.5% by 2034.
| Countries | Value CAGR (2024 to 2034) |
|---|---|
| USA | 1.5% |
| Germany | 1.5% |
| China | 4.9% |
| France | 2.5% |
| India | 5.5% |
| Spain | 2.8% |
| Australia | 2.3% |
| South Korea | 3.9% |
China suture needles market is poised to exhibit a CAGR of 4.9% between 2024 and 2034. Currently, it holds the highest share in the East Asia market, and the trend is expected to continue during the forecast period.
The low costs of production methods in China, combined with lower labor costs, contribute to the affordable cost of suture needles. This cost advantage will enable Chinese manufacturers to quote competitive prices in both the domestic and international markets, thereby attracting healthcare providers and distributors.
China has been able to corner a strong share in the global suture needles export market by leveraging the advantage brought in by its manufactural prowess to supply healthcare providers across the globe. This reach has given impetus to China's position in the international suture needles market.
Backed by fast infrastructure development in the Chinese healthcare industry, such as building new hospitals and surgical centers, suture needles have kept up their rapid growth. This growing market opens ample opportunities for local manufacturers to supply their products.
USA suture needles market is poised to exhibit a CAGR of 1.5% between 2024 and 2034. Currently, it holds the highest share in the North America market, and the trend is expected to continue during the forecast period.
Advanced infrastructure in health care, especially in the emerging economies, has altered access to surgical procedures and raised demand for suture needles. More hospitals, surgical centers, and better-equipped systems of healthcare have placed surgical interventions within the reach of many more people.
Other major factors that go on feeding this demand are technological innovations in the form of advanced absorbable sutures and new designs for the needle.
United States with enhanced healthcare standards globally, there will be a continuous demand for the highest quality surgical instruments, including suture needles. The increasing demand is due to the requirement of precision, safety, and efficiency in surgical procedures.
In USA suture needle manufacturers view this as a challenge and substantially invest in research and development activities to come out with new products meeting the emerging requirements of health institutions. It is key to serving diverse needs in modern surgical practice, such as innovations in needle design and materials.
Rigorous regulatory approvals in USA for medical devices are expected to serve as a barrier in the adoption of new technologies associated with suture needles, hence delaying their launch.
India’s suture needles market is poised to exhibit a CAGR of 5.5% between 2024 and 2034. Currently, it holds the highest share in the Asia Pacific market, and the trend is expected to continue during the forecast period.
Increasing number of metabolic and cardiovascular diseases has resulted in a higher volume of surgical procedures in India, which is on an increasing prevalence, driven by some important factors such as the spreading of chronic diseases, aging population, and improvements in medical technology.
Together, these factors are causing a higher demand for surgical interventions, hence substantial opportunity for companies specializing in suture needles.
It is expected that the growing volume of surgeries in India will offer a huge growth opportunity for suture needle manufacturers. Companies offering high quality and reliable suture needles can meet the rising demand ushered in by such trends.
With the rising incidences of surgical interventions, the requirement for advanced technologies in suture needles that can provide the best performance and help ensure patient safety will become critical. The growing market presents the brightest avenue for expansion and innovation in suture needles.
The section contains information about the leading segments in the industry. By shape, the straight shaped needles segment holds the highest market share of 40.7% in 2024.
| By Shape | Straight Shaped Needles |
|---|---|
| Value Share (2024) | 40.7% |
Straight shaped needles are very versatile and, therefore, suitable for most surgical applications. Their design allows for straightforward insertion and the simplicity they provide advantageous in simple suturing tasks and those that are complicated. This greatly explains their high usage among healthcare providers.
Simplicity of straight needles makes them easier to handle and control during surgeries. One of the reasons many surgeons usually go for straight needles is for predictable performance and user-friendly alignment, reducing the risk of complications, hence improving overall efficiency during procedures.
These needles find application in almost all surgical contexts, from the routine to specialized interventions. Their broad applicability across several types of sutures and tissues further hold their lead in the market. In general, straight-shaped needles are less complex to make compared to other more specialized designs for needles.
It is this ease in production cost that reflects in their prices, thus making them very attractive to most healthcare facilities, especially those under budget pressures.
| By Application | General Surgery |
|---|---|
| Value Share (2034) | 37.9% |
General surgery includes abdominal surgeries, hernia repairs, and soft tissue surgeries. Each of these requires an interesting set of suture needles for all kinds of surgical applications. As general surgery comprises several operations, the number and types of operations are so many that it consumes a large share of suture needles, hence contributing the most to the market share in this particular segment.
Most of the time, general surgical procedures are based on standardized protocols, one of which includes the use of special suture needles. It becomes very easy for healthcare providers to embrace and use the suture needles that will suit their needs under such standardization, as procurement and usage become very easy.
The following factors exert an influence that allows the segment of general surgery to dominate the market it represents a wide field of procedures, high frequency of surgeries, versatility in the use of needles, standardized practices, and generalized availability.
The market players are using strategies to stay competitive, such as product differentiation through innovative formulations, strategic partnerships with healthcare providers for distribution. Another key strategic focus of these companies is to actively look for strategic partners to bolster their product portfolios and expand their global market presence.
Recent Industry Developments in Suture Needles Market
In terms of shape, the industry is divided into half curved, compound cure shaped needles, straight shaped needles and j shaped needles.
In terms of type, the industry is segregated into blunt point needle, tapercut needle, reverse cutting needle, round bodied needle, conventional cutting needle and spatula needle
In terms of application, the industry is segregated into cardiovascular, general surgery, orhopedic procedures, gynecological procedures, veterinary procedures and other applications.
Key countries of North America, Latin America, Western Europe, Eastern, South Asia, East Asia and Middle East and Africa (MEA) have been covered in the report.
The global suture needles market is projected to witness CAGR of 4.9% between 2024 and 2034.
The global suture needles industry stood at USD 595.8 million in 2023.
The global suture needles market is anticipated to reach USD 1,008.3 million by 2034 end.
India is set to record the highest CAGR of 5.5% in the assessment period.
The key players operating in the global Suture Needles Market include Medtronic, Futura Surgicare Pvt. Ltd., Johnson & Johnson Medical N.V., Aurolab; Natsume Seisakusho Co., Ltd., Alfresa Pharma Corporation, Bear Medic Corporation, SUTUREX & RENODEX, Teleflex Incorporated, Smith & Nephew, Hu-Friedy Mfg. Co., LLC, FSSB Chirurgische Nadeln GmbH, Burtons Medical Equipment Ltd. and Advin Health Care.
1. Executive Summary
2. Industry Introduction, including Taxonomy and Market Definition
3. Market Trends and Success Factors, including Macro-Economic Factors, Market Dynamics, and Recent Industry Developments
4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034
5.1. By Shape
5.2. By Type
5.3. By Application
5.4. By Region
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Shape
6.1. Half Curved
6.2. Compound Cure Shaped Needles
6.3. Straight Shaped Needles
6.4. J Shaped Needles
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Type
7.1. Tablets & Capsules
7.2. Blunt Point Needle
7.3. Tapercut Needle
7.4. Reverse Cutting Needle
7.5. Round Bodied Needle
7.6. Conventional Cutting Needle
7.7. Spatula Needle
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application
8.1. Joint Health Support
8.2. Cardiovascular
8.3. General Surgery
8.4. Orhopedic Procedures
8.5. Gynecological Procedures
8.6. Veterinary Procedures
8.7. Other Applications
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
9.1. North America
9.2. Latin America
9.3. Western Europe
9.4. Eastern Europe
9.5. South Asia & Pacific
9.6. East Asia
9.7. Middle East & Africa
10. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
11. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
12. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
13. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
14. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
15. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
16. Middle East and Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
17. Sales Forecast 2024 to 2034 By Shape, By Type and By Application for 30 Countries
18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
19. Company Profile
19.1. Medtronic
19.2. Futura Surgicare Pvt. Ltd.
19.3. Johnson & Johnson Medical N.V.
19.4. Aurolab
19.5. Natsume Seisakusho Co. Ltd.
19.6. Alfresa Pharma Corporation
19.7. Bear Medic Corporation
19.8. SUTUREX & RENODEX
19.9. Teleflex Incorporated
19.10. Smith & Nephew
19.11. Hu-Friedy Mfg. Co. LLC
19.12. FSSB Chirurgische Nadlen GmbH
19.13. Burtons Medical Equipment Ltd.
19.14. Advin Health Care
Explore Healthcare Insights
View Reports
Suture Needles Market
